eli lilly phase 3 trial retatrutide Today, we shared new data from the latest study of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more Retatrutide Shows 28% Weight Loss

So I don't have the tissue available to make that, and I get to be grateful that I have this medication that allows me to have enough energy that protects my [00:57:00] heart, that protects my brain, and makes it so I can show up as a mom with my kids every day

Thus, there is a need for more effective weight-loss therapies

Some degree of weight gain after stopping GLP-1 medication can be normal

The strategies for when tirzepatide results plateau translate well to maintenance challenges, as many of the underlying principles are the same

Further evidence for the involvement of circulating GLP-1 in the responses to cocaine is that in humans, higher plasma levels of GLP-1 are associated with the subjective experience of cocaine (Bouhlal et al., 2017)

Modern GLP-1 medications are designed to mimic this exact hormone, but with a longer-lasting effect